189 related articles for article (PubMed ID: 950324)
1. Naturally-occurring beta-lactamase inhibitors with antibacterial activity.
Brown AG; Butterworth D; Cole M; Hanscomb G; Hood JD; Reading C; Rolinson GN
J Antibiot (Tokyo); 1976 Jun; 29(6):668-9. PubMed ID: 950324
[No Abstract] [Full Text] [Related]
2. Clavulanic acid: a beta-lactamase-inhiting beta-lactam from Streptomyces clavuligerus.
Reading C; Cole M
Antimicrob Agents Chemother; 1977 May; 11(5):852-7. PubMed ID: 879738
[TBL] [Abstract][Full Text] [Related]
3. Four further antibiotics related to olivanic acid produced by Streptomyces olivaceus: fermentation, isolation, characterisation and biosynthetic studies.
Box SJ; Hood JD; Spear SR
J Antibiot (Tokyo); 1979 Dec; 32(12):1239-47. PubMed ID: 317283
[TBL] [Abstract][Full Text] [Related]
4. Letter: Two beta-lactamase inhibitors produced by a streptomyces.
Umezawa H; Mitsuhashi S; Hamada M; Iyobe S; Takahashi S
J Antibiot (Tokyo); 1973 Jan; 26(1):51-4. PubMed ID: 4781280
[No Abstract] [Full Text] [Related]
5. Olivanic acids, a family of beta-lactam antibiotics with beta-lactamase inhibitory properties produced by Streptomyces species. II. Isolation and characterisation of the olivanic acids MM 4550, MM 13902 and MM 17880 from Streptomyces olivaceus.
Hood JD; Box SJ; Verrall MS
J Antibiot (Tokyo); 1979 Apr; 32(4):295-304. PubMed ID: 468716
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of beta-lactamase: a continuing story.
Hamilton-Miller JM
J Antimicrob Chemother; 1977 May; 3(3):195-6. PubMed ID: 586225
[No Abstract] [Full Text] [Related]
7. [beta-lactamase inhibitors].
Navashin SM; Nikolaeva TI; Rozenfel'd GS
Antibiotiki; 1980 Jan; 25(1):51-67. PubMed ID: 6986839
[No Abstract] [Full Text] [Related]
8. Asparenomycin A, a new carbapenem antibiotic.
Tanaka K; Shoji J; Terui Y; Tsuji N; Kondo E; Mayama M; Kawamura Y; Hattori T; Matsumoto K; Yoshida T
J Antibiot (Tokyo); 1981 Jul; 34(7):909-11. PubMed ID: 6974725
[No Abstract] [Full Text] [Related]
9. Olivanic acids, a family of beta-lactam antibiotics with beta-lactamase inhibitory properties produced by Streptomyces species. I. Detection, properties and fermentation studies.
Butterworth D; Cole M; Hanscomb G; Rolinson GN
J Antibiot (Tokyo); 1979 Apr; 32(4):287-94. PubMed ID: 468715
[TBL] [Abstract][Full Text] [Related]
10. Using β-lactam/β-lactamase inhibitors for infections due to extended-spectrum β-lactamase-producing Enterobacteriaceae to slow the emergence of carbapenem-resistant Enterobacteriaceae.
Watkins RR; Deresinski S
Expert Rev Anti Infect Ther; 2017 Oct; 15(10):893-895. PubMed ID: 28914107
[No Abstract] [Full Text] [Related]
11. Antibacterial activity of an oral penem, Sch 29482.
Neu HC; Labthavikul P
J Antimicrob Chemother; 1982 Feb; 9 Suppl C():49-57. PubMed ID: 6977533
[No Abstract] [Full Text] [Related]
12. Superbugs and Superdrugs: a focus on antibacterials--6th annual SMi conference.
Georgopapadakou N
Expert Opin Emerg Drugs; 2004 May; 9(1):191-5. PubMed ID: 15155144
[No Abstract] [Full Text] [Related]
13. A novel beta-lactamase inhibitor, SF-2103 A produced by a Streptomyces.
Ito T; Ezaki N; Ohba K; Amano S; Kondo Y; Miyado HS; Shomura T; Sezaki M; Niwa T; Kojima M; Inouye S; Yamada Y; Nida T
J Antibiot (Tokyo); 1982 Apr; 35(4):533-5. PubMed ID: 6980216
[No Abstract] [Full Text] [Related]
14. Sch 29482, a new oral penem: comparative in-vitro activity, beta-lactamase stability and inhibition.
Barry AL; Jones RN; Wilson HW; Badal RE; Thornsberry C
J Antimicrob Chemother; 1982 Feb; 9 Suppl C():97-112. PubMed ID: 6977536
[No Abstract] [Full Text] [Related]
15. Studies on the biosynthesis of clavulanic acid. I. Incorporation of 13C-labelled precursors.
Elson SW; Oliver RS
J Antibiot (Tokyo); 1978 Jun; 31(6):586-92. PubMed ID: 681240
[TBL] [Abstract][Full Text] [Related]
16. Synergistic activity of cefoperazone in combination with beta-lactamase inhibitors.
Fu KP; Neu HC
J Antimicrob Chemother; 1981 Mar; 7(3):287-92. PubMed ID: 6268598
[No Abstract] [Full Text] [Related]
17. Comparative antibacterial properties in vitro of seven olivanic acid derivatives: MM 4550, MM 13902, MM 17880, MM 22380, MM 22381, MM 22382 and MM 22383.
Basker MJ; Boon RJ; Hunter PA
J Antibiot (Tokyo); 1980 Aug; 33(8):878-84. PubMed ID: 6968745
[TBL] [Abstract][Full Text] [Related]
18. Susceptibility of clinical isolates to expanded-spectrum beta-lactams alone and in the presence of beta-lactamase inhibitors.
Qadri SM; Ueno Y; Cunha BA
Chemotherapy; 1996; 42(5):334-42. PubMed ID: 8874972
[TBL] [Abstract][Full Text] [Related]
19. Sch 29482: comparative activity against Enterobacteriaceae multiply-resistant to beta-lactam antibiotics and mycobacteria.
Sanders CC; Sanders WE
J Antimicrob Chemother; 1982 Feb; 9 Suppl C():59-69. PubMed ID: 6977534
[No Abstract] [Full Text] [Related]
20. Activity of the beta-lactamase inhibitor BRL 42715 against cephalosporinases produced by Enterobacteriaceae.
Zhou XY; Kitzis MD; Acar JF; Gutmann L
J Antimicrob Chemother; 1993 Apr; 31(4):473-80. PubMed ID: 8514645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
